Product information
From Health Canada
Current status:
Cancelled Post Market
Current status date:
1997-07-30
Original market date: See footnote 1
1960-12-31
Product name:
HYPAQUE ORAL POWDER 0.9974G/G
DIN:
02026988 Electronic product monograph is not available
Company:
SANOFI CANADA, INC.
15 Allstate Pky
Markham
Ontario
Canada
L3R 5B4
Class:
Human
Dosage form(s):
Powder
Route(s) of administration:
Oral , Rectal
Number of active ingredient(s):
1
Schedule(s):
Ethical
American Hospital Formulary Service (AHFS): See footnote 3
36:68.00
Anatomical Therapeutic Chemical (ATC): See footnote 4
V08AA01 DIATRIZOIC ACID
Active ingredient group (AIG) number:See footnote5
0101806002
Active ingredient(s) | Strength |
---|---|
DIATRIZOATE SODIUM | 997.4 MG / G |